NnBU [FROZEN]

NnBU [FROZEN]

Created using Figma
Created using Figma
Backed by blockchain technology, NnBU’s world first, unique and revolutionary healthcare device will support C-section new-borns by giving a highly specialised massage of the torso, replicating various processes experienced during labour. A child born through caesarean may not experience the same stimulants of natural births and, in some cases, the breathing and hormonal processes may not be immediately initiated leading to problems in later life. Through a token pre-sale scheduled to run from Monday March 19 2018 to Sunday March 25 2018 and a main sale scheduled to run from Monday March 26 2018 to Wednesday April 25 2018, NnBU will issue passive income tokens which, in aggregate and assuming the target contribution is attained, 12.5% of the annual revenue will be distributed to token holders.
Mar 26, 2018
Apr 25, 2018
100% completed
Raised funds - no Data
past
Token Details
Ticker
NNBU
Accepted Currencies
ETH
Company Details
Registered Country
Cyprus
Additional Details
KYC
Yes
Categories
Health

About NnBU [FROZEN]

The purpose of this Initial Coin Offering (“ICO”) is for the company NNBU HOLDINGS (derived from Neo-natal Birth Unit) to raise sufficient funds to i) complete the design of its medical device, ii) ensure that the Company can prepare an assembly plant for the device once the design is completed, certified and readied for manufacture, and iii) be able to introduce the device to the market. The device aims to replicate for a baby born by Caesarean-section some of the physical stresses undergone by a baby delivered naturally. The Company aims to raise the equivalent of €15,000,000 (Fifteen Million Euros), the Target Contribution, and will issue “passive income” tokens (a token which entitles the holder to receive payments without having to take any further action other than those naturally linked to collecting payments) which, in aggregate and assuming the target contribution is attained, would receive each year a figure equal to 12.5% of the Company’s sales. Based on the Company’s financial projections, this level of pay-out would give contributors an internal rate of return of 36.9%. The Token section of this White Paper (Section E) explains this in greater detail. It should be noted that investor pay-outs would only commence after the development period of the device has finished, this period being estimated at a maximum of 2 years. The commitment to pay a percentage of sales to Token holders will be included in a Smart Contract in the usual way, but in addition, contributors in this ICO will also become party to a conventional legal contract enforceable in a court of law.

Features

NnBU device, situated in hospitals and clinics, used straight after the baby is born, seeks to reproduce part of these positive stresses in a controlled manner. This gives the baby the benefits of a natural birth, even though they were born by Caesarean-section.

The device applies a controlled pressure to the baby in different sections of the torso for a predetermined period while also holding the baby in a warm, comfortable environment. Also, because most C-section babies are asleep when delivered, the NnBU device also focuses lighton the baby’s fontanel in order to create a comfortable waking process for the newborn baby.

NnBU [FROZEN] Roadmap

  • May 2018

  • Development of the medical device in cooperation with Fraunhofer IPA;
    Device certification by DMTpe GmbH;
    Global intellectual property protection;
  • May 2020

  • Germany, Austria & Switzerland (DACH) market entry;
  • May 2018

  • Development of the medical device in cooperation with Fraunhofer IPA;
    Device certification by DMTpe GmbH;
    Global intellectual property protection;
  • May 2020

  • Germany, Austria & Switzerland (DACH) market entry;
  • Read More
  • May 2021

  • Investors pay-out in Y1;
    France & Benelux market entry;
  • May 2021

  • Investors pay-out in Y1;
    France & Benelux market entry;
  • November 2021

  • Brasil & Argentina market entry;
  • March 2022

  • Mexico market entry;
  • May 2022

  • US and Canada market entry; Investors pay-out in Y2;
  • July 2022

  • Other European countries (UK, Italy, Portugal, Spain, Poland, Hungary, Slovakia, Czech Republic) market entry;
  • May 2022

  • US and Canada market entry; Investors pay-out in Y2;
  • July 2022

  • Other European countries (UK, Italy, Portugal, Spain, Poland, Hungary, Slovakia, Czech Republic) market entry;
  • February 2023

  • Turkey and Egypt market entry.
  • February 2023

  • Turkey and Egypt market entry.
  • May 2023

  • Investors pay-out in Y3;
  • February 2024

  • China, India and Indonesia market entry.
  • February 2024

  • China, India and Indonesia market entry.
  • May 2024

  • Investors pay-out in Y4;
  • May 2024

  • Investors pay-out in Y4;
  • May 2025

  • Investors pay-out in Y5;
  • May 2025

  • Investors pay-out in Y5;

Activity

NnBU [FROZEN] Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Frederic Vo Van
CEO
unverified
Johannes Schenck
COO
unverified
Claus Peters
CFO
unverified
Dr Serge Bakoa
Attorney At Law
unverified
Ben Jafari
Comply Advantage
unverified
Max Pokam
Project Manager
unverified
Gustavo Guimarães
Smart Contract Developer
unverified
Jürgen Haeberle
CEO/co-founder and partner of DMT GmbH
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

2 ICO

$9 850 000

Tina Fotherby
Public Relations Advisor
unverified
Mike Boutwell
Blockchain Technology Advisor
unverified
Sidney Perera
Corporate Finance Advisor
unverified
Srecko Velimirovic
Corporate Finance Advisor
unverified
Andreas Achleithner
Project Advisor
unverified
Petra Sacher
Medical Advisor
unverified
N/A
5.0 9
ICO Profile Vision Activity Potential Product Team
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO